Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 30

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design

Teymournejad, Omid, Montgomery, Christopher P. · 2021 · Frontiers in Immunology

Abstract

Recurrent S. aureus infections are common, suggesting that natural immune responses are not protective. All candidate vaccines tested thus far have failed to protect against S. aureus infections, highlighting an urgent need to better understand the mechanisms by which the bacterium interacts with the host immune system to evade or prevent protective immunity. Although there is evidence in murine models that both cellular and humoral immune responses are important for protection against S. aureus, human studies suggest that T cells are critical in determining susceptibility to infection. This review will use an “anatomic” approach to systematically outline the steps necessary in generating a T cell-mediated immune response against S. aureus. Through the processes of bacterial uptake by antigen presenting cells, processing and presentation of antigens to T cells, and differentiation and proliferation of memory and effector T cell subsets, the ability of S. aureus to evade or inhibit each step of the T-cell mediated response will be reviewed. We hypothesize that these interactions result in the redirection of immune responses away from protective antigens, thereby precluding the establishment of “natural” memory and potentially inhibiting the efficacy of vaccination. It is anticipated that this approach will reveal important implications for future design of vaccines to prevent these infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2021.633672

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 107

  1. Sakr, 2018, Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections, Front Microbiol, 9, 2419, 10.3389/fmicb.2018.02419 · DOI · Paper page
  2. Kumar, 2015, High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department, J Clin Microbiol, 53, 810, 10.1128/JCM.03221-14 · DOI
  3. Fritz, 2013, A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection, Clin Infect Dis, 56, 1554, 10.1093/cid/cit123 · DOI
  4. Miller, 2015, Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors, Clin Infect Dis, 60, 753, 10.1093/cid/ciu943 · DOI
  5. Miller, 2020, Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS Microbiol Rev, 44, 123, 10.1093/femsre/fuz030 · DOI · Paper page
  6. Fowler, 2013, Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial, JAMA, 309, 1368, 10.1001/jama.2013.3010 · DOI · Paper page
  7. Gurtman, 2019, The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery, Hum Vaccin Immunother, 15, 358, 10.1080/21645515.2018.1523093 · DOI
  8. Verkaik, 2009, Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus, J Infect Dis, 199, 625, 10.1086/596743 · DOI · Paper page
  9. Blum, 2013, Pathways of antigen processing, Annu Rev Immunol, 31, 443, 10.1146/annurev-immunol-032712-095910 · DOI · Paper page
  10. Wieczorek, 2017, Major Histocompatibility Complex, Front Immunol, 8, 292, 10.3389/fimmu.2017.00292 · DOI · Paper page
  11. Hirosue, 2015, Modes of antigen presentation by lymph node stromal cells and their immunological implications, Front Immunol, 6, 446, 10.3389/fimmu.2015.00446 · DOI
  12. Pennock, 2013, T cell responses: naive to memory and everything in between, Adv Physiol Educ, 37, 273, 10.1152/advan.00066.2013 · DOI · Paper page
  13. Romani, 2010, Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin, Immunol Rev, 234, 120, 10.1111/j.0105-2896.2009.00886.x · DOI · Paper page
  14. Honold, 2018, Resident and monocyte-derived macrophages in cardiovascular disease, Circ Res, 122, 113, 10.1161/CIRCRESAHA.117.311071 · DOI · Paper page
  15. Gaudino, 2019, Cross-talk between antigen presenting cells and t cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis, Front Immunol, 10, 360, 10.3389/fimmu.2019.00360 · DOI · Paper page
  16. Sallusto, 2002, The instructive role of dendritic cells on T-cell responses, Arthritis Res, 10.1186/ar567 · DOI
  17. Thammavongsa, 2015, Staphylococcal manipulation of host immune responses, Nat Rev Microbiol, 13, 529, 10.1038/nrmicro3521 · DOI · Paper page
  18. Frucht, 2001, IFN-gamma production by antigen-presenting cells: mechanisms emerge, Trends Immunol, 22, 556, 10.1016/S1471-4906(01)02005-1 · DOI · Paper page
  19. Mutyambizi, 2009, The balance between immunity and tolerance: the role of Langerhans cells, Cell Mol Life Sci, 66, 831, 10.1007/s00018-008-8470-y · DOI
  20. Wu, 2014, Dendritic cells during Staphylococcus aureus infection: subsets and roles, J Transl Med, 12, 358, 10.1186/s12967-014-0358-z · DOI
  21. Coutant, 1999, Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen, Toxicol Sci, 52, 189, 10.1093/toxsci/52.2.189 · DOI
  22. Schindler, 2012, Dendritic cells are central coordinators of the host immune response to Staphylococcus aureus bloodstream infection, Am J Pathol, 181, 1327, 10.1016/j.ajpath.2012.06.039 · DOI
  23. Richardson, 2019, PSM Peptides from community-associated methicillin-resistant Staphylococcus aureus impair the adaptive immune response via modulation of dendritic cell subsets in vivo, Front Immunol, 10, 995, 10.3389/fimmu.2019.00995 · DOI
  24. Frodermann, 2011, A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus, J Infect Dis, 204, 253, 10.1093/infdis/jir276 · DOI
  25. Alonzo, 2014, The bicomponent pore-forming leucocidins of Staphylococcus aureus, Microbiol Mol Biol Rev, 78, 199, 10.1128/MMBR.00055-13 · DOI · Paper page
  26. Spaan, 2017, Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors, Nat Rev Microbiol, 15, 435, 10.1038/nrmicro.2017.27 · DOI · Paper page
  27. Yoong, 2013, The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond, Curr Opin Microbiol, 16, 63, 10.1016/j.mib.2013.01.012 · DOI
  28. Seilie, 2017, Staphylococcus aureus pore-forming toxins: the interface of pathogen and host complexity, Semin Cell Dev Biol, 72, 101, 10.1016/j.semcdb.2017.04.003 · DOI · Paper page
  29. Wilke, 2010, Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury, Proc Natl Acad Sci USA, 107, 13473, 10.1073/pnas.1001815107 · DOI · Paper page
  30. Becker, 2014, Tissue-specific patterning of host innate immune responses by Staphylococcus aureus alpha-toxin, J Innate Immun, 6, 619, 10.1159/000360006 · DOI
  31. Berube, 2013, Staphylococcus aureus alpha-toxin: nearly a century of intrigue, Toxins., 5, 1140, 10.3390/toxins5061140 · DOI · Paper page
  32. Lee, 2020, Staphylococcus aureus toxin suppresses antigen-specific T cell responses, J Clin Invest, 130, 1122, 10.1172/JCI130728 · DOI
  33. Sampedro, 2014, Targeting Staphylococcus aureus alpha-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections, J Infect Dis, 210, 1012, 10.1093/infdis/jiu223 · DOI
  34. Yang, 2020, Antibody-mediated protection against Staphylococcus aureus dermonecrosis: synergy of toxin neutralization and neutrophil recruitment, J Invest Dermatol, 10.1016/j.jid.2020.09.001 · DOI
  35. Akram, 2012, Immunodominance: a pivotal principle in host response to viral infections, Clin Immunol, 143, 99, 10.1016/j.clim.2012.01.015 · DOI
  36. Knight, 2020, Imprinting, immunodominance, and other impediments to generating broad influenza immunity, Immunol Rev, 296, 191, 10.1111/imr.12900 · DOI
  37. Dryla, 2005, Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients, Clin Diagn Lab Immunol, 12, 387, 10.1128/CDLI.12.3.387-398.2005 · DOI · Paper page
  38. Wu, 2018, Prevalence of IgG and neutralizing antibodies against Staphylococcus aureus alpha-toxin in healthy human subjects and diverse patient populations, Infect Immun, 86, e00671, 10.1128/IAI.00671-17 · DOI
  39. Hermos, 2010, High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection, Clin Infect Dis, 51, 1138, 10.1086/656742 · DOI
  40. Lorenz, 2000, Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus, FEMS Immunol Med Microbiol, 29, 145, 10.1111/j.1574-695X.2000.tb01517.x · DOI
  41. Koedijk, 2017, Differential epitope recognition in the immunodominant staphylococcal antigen A of Staphylococcus aureus by mouse versus human IgG antibodies, Sci Rep, 7, 8141, 10.1038/s41598-017-08182-9 · doi:10.1038/s41598-017-08182-9
  42. Thomsen, 2014, Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB, Infect Immun, 82, 1234, 10.1128/IAI.01558-13 · DOI
  43. Pelzek, 2018, Human memory B cells targeting Staphylococcus aureus exotoxins are prevalent with skin and soft tissue infection, mBio, 9, e02125, 10.1128/mBio.02125-17 · DOI
  44. Radke, 2018, Hierarchy of human IgG recognition within the Staphylococcus aureus immunome, Sci Rep, 8, 13296, 10.1038/s41598-018-31424-3 · DOI
  45. Soltan, 2020, Design of Staphylococcus aureus new vaccine candidates with B and T cell epitope mapping. reverse vaccinology, and immunoinformatics, OMICS, 24, 195, 10.1089/omi.2019.0183 · DOI
  46. Si, 2020, Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination, Sci Adv, 6, eaaw7713, 10.1126/sciadv.aaw7713 · DOI
  47. Nikcevich, 1994, Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo, J Immunol, 153, 1015, 10.4049/jimmunol.153.3.1015 · doi:10.4049/jimmunol.153.3.1015
  48. Yu, 2015, Identification of CD4+ T-cell epitopes on iron-regulated surface determinant B of Staphylococcus aureus, Microb Pathog, 89, 108, 10.1016/j.micpath.2015.09.006 · DOI
  49. Brown, 2015, Memory Th1 cells are protective in invasive Staphylococcus aureus infection, PLoS Pathog, 11, e1005226, 10.1371/journal.ppat.1005226 · DOI · Paper page
  50. Uebele, 2017, Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus, PLoS Pathog, 13, e1006387, 10.1371/journal.ppat.1006387 · DOI
  51. Kolata, 2015, The FALL OF A Dogma? Unexpected high T-cell memory response to Staphylococcus aureus in humans, J Infect Dis, 212, 830, 10.1093/infdis/jiv128 · DOI
  52. Oprea, 2013, Reverse-vaccinology strategy for designing T-cell epitope candidates for Staphylococcus aureus endocarditis vaccine, Biologicals, 41, 148, 10.1016/j.biologicals.2013.03.001 · DOI
  53. Monto, 2017, The doctrine of original antigenic sin: separating good from evil, J Infect Dis, 215, 1782, 10.1093/infdis/jix173 · DOI · Paper page
  54. Francis, 1960, On the doctrine of original antigenic sin, Proc. Am. Philosoph. Soc, 104, 572
  55. Kim, 2012, Strategies to alleviate original antigenic sin responses to influenza viruses, Proc Natl Acad Sci USA, 109, 13751, 10.1073/pnas.0912458109 · doi:10.1073/pnas.0912458109
  56. Pauli, 2014, Staphylococcus aureus infection induces protein A-mediated immune evasion in humans, J Exp Med, 211, 2331, 10.1084/jem.20141404 · DOI
  57. Henry, 2018, From original antigenic sin to the universal influenza virus vaccine, Trends Immunol, 39, 70, 10.1016/j.it.2017.08.003 · DOI · Paper page
  58. Blackwell, 2009, HLA and infectious diseases, Clin Microbiol Rev, 22, 370, 10.1128/CMR.00048-08 · DOI · Paper page
  59. DeLorenze, 2016, Polymorphisms in HLA class II genes are associated with susceptibility to Staphylococcus aureus infection in a white population, J Infect Dis, 213, 816, 10.1093/infdis/jiv483 · DOI
  60. Cyr, 2017, Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping, Genes Immun, 18, 95, 10.1038/gene.2017.6 · DOI
  61. Xu, 2012, Staphylococcal superantigens in colonization and disease, Front Cell Infect Microbiol, 2, 52, 10.3389/fcimb.2012.00052 · DOI · Paper page
  62. Krakauer, 2013, Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions, Toxins., 5, 1629, 10.3390/toxins5091629 · DOI
  63. Muller-Alouf, 2001, Superantigen bacterial toxins: state of the art, Toxicon, 39, 1691, 10.1016/S0041-0101(01)00156-8 · doi:10.1016/s0041-0101(01)00156-8
  64. Nizet, 2007, Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets, J Allergy Clin Immunol, 120, 13, 10.1016/j.jaci.2007.06.005 · DOI · Paper page
  65. Watson, 2012, Superantigen-induced CD4 memory T cell anergy. I. Staphylococcal enterotoxin B induces Fyn-mediated negative signaling, Cell Immunol, 276, 16, 10.1016/j.cellimm.2012.02.003 · DOI
  66. Lee, 2018, Induction of immunosuppressive CD8(+)CD25(+)FOXP3(+) regulatory T cells by suboptimal stimulation with staphylococcal enterotoxin C1, J Immunol, 200, 669, 10.4049/jimmunol.1602109 · DOI
  67. Venkatasubramaniam, 2019, TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens, Sci Rep, 9, 3279, 10.1038/s41598-019-39890-z · DOI
  68. Gampfer, 2002, Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome, Vaccine, 20, 1354, 10.1016/S0264-410X(01)00470-4 · doi:10.1016/s0264-410x(01)00470-4
  69. Hu, 2003, Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection, J Infect Dis, 188, 743, 10.1086/377308 · DOI
  70. Weinreich, 2011, Postselection thymocyte maturation and emigration are independent of IL-7 and ERK5, J Immunol, 186, 1343, 10.4049/jimmunol.1002238 · DOI
  71. Ng, 2010, Role of secondary lymphoid tissues in primary and memory T-cell responses to a transplanted organ, Transplant Rev., 24, 32, 10.1016/j.trre.2009.09.003 · DOI
  72. Bonelli, 2014, Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes, Curr Top Microbiol Immunol, 381, 279, 10.1007/82_2014_371 · DOI
  73. Zhu, 2010, Differentiation of effector CD4 T cell populations, Annu Rev Immunol, 28, 445, 10.1146/annurev-immunol-030409-101212 · DOI · Paper page
  74. Hampton, 2019, Lymphatic migration of immune cells, Front Immunol, 10, 1168, 10.3389/fimmu.2019.01168 · DOI · Paper page
  75. Broker, 2016, The T cell response to Staphylococcus aureus, Pathogens, 5, 31, 10.3390/pathogens5010031 · DOI
  76. Miller, 2011, Immunity against Staphylococcus aureus cutaneous infections, Nat Rev Immunol, 11, 505, 10.1038/nri3010 · DOI · Paper page
  77. Ge, 2020, Biology of interleukin-17 and its pathophysiological significance in sepsis, Front Immunol, 11, 1558, 10.3389/fimmu.2020.01558 · DOI · Paper page
  78. Renner, 2008, Identification of a 27 kDa protein in patients with anaphylactic reactions to mango, J Investig Allergol Clin Immunol, 18, 476
  79. Dellinger, 2008, Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008, Crit Care Med, 36, 296, 10.1097/01.CCM.0000298158.12101.41 · DOI · Paper page
  80. Hidron, 2010, Methicillin-resistant Staphylococcus aureus in HIV-infected patients, Infect Drug Resist, 3, 73, 10.2147/IDR.S7641 · DOI
  81. Reiss-Mandel, 2018, Staphylococcus aureus colonization induces strain-specific suppression of interleukin-17, Infect Immun, 86, e00834, 10.1128/IAI.00834-17 · DOI
  82. Cho, 2010, IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice, J Clin Invest, 120, 1762, 10.1172/JCI40891 · DOI · Paper page
  83. Montgomery, 2014, Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A, Infect Immun, 82, 2125, 10.1128/IAI.01491-14 · DOI
  84. Karauzum, 2017, Lethal CD4 T cell responses induced by vaccination against Staphylococcus aureus bacteremia, J Infect Dis, 215, 1231, 10.1093/infdis/jix096 · DOI
  85. Kim, 2019, Interactions between atopic dermatitis and staphylococcus aureus infection: clinical implications, Allergy Asthma Immunol Res, 11, 593, 10.4168/aair.2019.11.5.593 · DOI · Paper page
  86. Aujla, 2008, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, Nat Med, 14, 275, 10.1038/nm1710 · DOI · Paper page
  87. Cheng, 2012, Role of gamma-delta T cells in host response against Staphylococcus aureus-induced pneumonia, BMC Immunol, 13, 38, 10.1186/1471-2172-13-38 · DOI
  88. Cooper, 2020, Activation of human Vdelta2(+) gammadelta T Cells by Staphylococcus aureus promotes enhanced anti-staphylococcal adaptive immunity, J Immunol, 205, 1039, 10.4049/jimmunol.2000143 · DOI
  89. Nygaard, 2012, Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection, PLoS ONE, 7, e36532, 10.1371/journal.pone.0036532 · DOI
  90. Bonifacius, 2020, Staphylococcus aureus Alpha-toxin limits type 1 while fostering type 3 immune responses, Front Immunol, 11, 1579, 10.3389/fimmu.2020.01579 · DOI
  91. Leech, 2019, Toxin-triggered interleukin-1 receptor signaling enables early-life discrimination of pathogenic versus commensal skin bacteria, Cell Host Microbe, 26, 795, 10.1016/j.chom.2019.10.007 · DOI
  92. Kaesler, 2016, Staphylococcus aureus-derived lipoteichoic acid induces temporary T-cell paralysis independent of Toll-like receptor 2, J Allergy Clin Immunol, 138, 780, 10.1016/j.jaci.2015.11.043 · DOI
  93. Sanchez, 2017, O-acetylation of peptidoglycan limits helper T cell priming and permits Staphylococcus aureus reinfection, Cell Host Microbe, 10.1016/j.chom.2017.08.008 · DOI
  94. Orfali, 2019, Staphylococcal enterotoxins modulate the effector CD4(+) T cell response by reshaping the gene expression profile in adults with atopic dermatitis, Sci Rep, 9, 13082, 10.1038/s41598-019-49421-5 · DOI
  95. Tebartz, 2015, A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection, J Immunol, 194, 1100, 10.4049/jimmunol.1400196 · DOI
  96. Tong, 2015, Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management, Clin Microbiol Rev, 28, 603, 10.1128/CMR.00134-14 · DOI · Paper page
  97. Redi, 2018, Staphylococcus aureus vaccine preclinical and clinical development: current state of the art, New Microbiol, 41, 208
  98. Fattom, 2004, Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine. (StaphVAX) in hemodialysis patients, Vaccine, 23, 656, 10.1016/j.vaccine.2004.06.043 · DOI
  99. Frenck, 2017, Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine. (SA4Ag): results from a first-in-human randomised, placebo-controlled phase 1/2 study, Vaccine, 35, 375, 10.1016/j.vaccine.2016.11.010 · DOI
  100. Proctor, 2012, Challenges for a universal Staphylococcus aureus vaccine, Clin Infect Dis, 54, 1179, 10.1093/cid/cis033 · DOI · Paper page
  101. Oscherwitz, 2015, Identification and validation of a linear protective neutralizing epitope in the beta-pore domain of alpha toxin, PLoS ONE, 10, e0116882, 10.1371/journal.pone.0116882 · DOI
  102. Salgado-Pabon, 2014, Staphylococcus aureus beta-toxin production is common in strains with the beta-toxin gene inactivated by bacteriophage, J Infect Dis, 210, 784, 10.1093/infdis/jiu146 · DOI
  103. Kim, 2014, Mouse models for infectious diseases caused by Staphylococcus aureus, J Immunol Methods, 410, 88, 10.1016/j.jim.2014.04.007 · DOI · Paper page
  104. Bagnoli, 2015, Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus, Proc Natl Acad Sci USA, 112, 3680, 10.1073/pnas.1424924112 · DOI · Paper page
  105. Monaci, 2015, MF59- and Al(OH)3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers, Front Immunol, 6, 439, 10.3389/fimmu.2015.00439 · DOI
  106. Proctor, 2015, Recent developments for Staphylococcus aureus vaccines: clinical and basic science challenges, Eur Cell Mater, 30, 315, 10.22203/eCM.v030a22 · DOI
  107. Engelman, 2014, Invasive Staphylococcus aureus infections in children in tropical Northern Australia, J Pediatric Infect Dis Soc, 3, 304, 10.1093/jpids/piu013 · DOI

Cited by

See all 30

Metadata

Authors
Teymournejad, O., & Montgomery, C. P.
Venue
Frontiers in Immunology
Published
2021-02-22
Volume
12
ISSN
1664-3224
Cited by
30
References
7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design. https://app.cochat.ai/papers/10.3389/fimmu.2021.633672
The paper
Teymournejad, O., & Montgomery, C. P. (2021). Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.633672

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.